Sarcopenia, the age-related loss of muscle mass and function, is a multifactorial condition primarily driven by chronic disuse and anabolic resistance. Prevention largely centres on progressive resistance training and adequate protein intake, though the precise interplay of contributing factors remains an active area of research.
Sarcopenia is primarily caused by a combination of reduced physical activity, inadequate protein intake, and age-related changes in muscle protein synthesis and degradation pathways. The most effective prevention strategies involve regular, progressive resistance training combined with sufficient dietary protein.
Sarcopenia is defined as a progressive and generalised skeletal muscle disorder involving the accelerated loss of muscle mass and function (strength and/or performance) (Cruz-Jentoft et al., Age and Ageing, 2019). Its aetiology is multifactorial, with age being the primary non-modifiable risk factor. Longitudinal studies consistently demonstrate a decline in muscle mass and strength from the third decade of life, accelerating after 60 years of age (Stenholm et al., J Gerontol A Biol Sci Med Sci, 2008). Key physiological drivers include chronic low-grade inflammation, hormonal changes (e.g., declining testosterone and oestrogen, increasing cortisol), mitochondrial dysfunction, and oxidative stress. However, the most robustly supported causes are behavioural: physical inactivity and insufficient protein intake. Systematic reviews and meta-analyses of randomised controlled trials (RCTs) unequivocally show that progressive resistance training significantly increases muscle mass, strength, and functional capacity in older adults (Peterson et al., J Strength Cond Res, 2011). Similarly, adequate protein intake (typically 1.0-1.2 g/kg body weight/day, with emphasis on even distribution throughout the day and higher doses at key meals) has been shown to support muscle protein synthesis and mitigate muscle loss, especially when combined with exercise (Morton et al., J Gerontol A Biol Sci Med Sci, 2018).
Sarcopenia is characterised by a progressive and generalised loss of skeletal muscle mass and strength, with a consequent increased risk of adverse outcomes such as physical disability, poor quality of life and death.
— Cruz-Jentoft et al., Age and Ageing 2019
Harvard Health's guidance on sarcopenia correctly identifies that it is a common and serious condition impacting quality of life and longevity. They accurately highlight the critical roles of regular exercise, particularly strength training, and adequate protein intake in both preventing and managing sarcopenia. Their emphasis on starting early and maintaining these habits throughout life aligns with the robust evidence base. The recognition that muscle loss is not an inevitable or untreatable part of ageing, but rather a modifiable condition, is a crucial message that Harvard Health effectively communicates.
While Harvard Health correctly identifies the primary interventions, the discussion can sometimes oversimplify the complexity of sarcopenia's aetiology and the nuances of optimal intervention. For instance, while protein intake is crucial, the specific timing and type of protein (e.g., leucine-rich sources) are important considerations for maximising muscle protein synthesis, especially in older adults who experience 'anabolic resistance' (McGregor et al., J Appl Physiol (1985), 2014). Furthermore, the role of other micronutrients (e.g., vitamin D) and the precise contribution of various hormonal changes beyond just declining sex hormones (e.g., growth hormone resistance, thyroid function) are often discussed mechanistically but lack the same level of Tier I evidence for direct causality or preventative efficacy as exercise and protein. The interplay of genetics and environment also receives less attention than its true contribution to individual variability in muscle ageing.
For individuals aiming to prevent sarcopenia and maintain functional independence, the evidence points towards consistent engagement in progressive resistance training at least two to three times per week, targeting all major muscle groups. This should be coupled with a dietary protein intake of at least 1.0-1.2 grams per kilogram of body weight per day, distributed across meals. Prioritising protein sources rich in leucine, such as dairy, meat, and soy, can further enhance muscle protein synthesis. While other factors like vitamin D status and chronic disease management are important for overall health, exercise and protein remain the cornerstone of sarcopenia prevention. Starting these habits earlier in life provides a greater 'muscle reserve' for later years.
Vitaei verdict
Supported by the evidence. The primary causes of sarcopenia are well-established, and the preventative strategies of resistance training and adequate protein intake are strongly supported by Tier I evidence.